1. Signaling Pathways
  2. NF-κB
  3. NF-κB

NF-κB (核因子κB)

Nuclear factor-κB; Nuclear factor-kappaB

NF-κB(活化 B 细胞的核因子 κ 轻链增强子)是一种控制 DNA 转录的蛋白质复合物。NF-κB 存在于几乎所有动物细胞类型中,并参与细胞对压力、细胞因子、自由基、紫外线照射、氧化 LDL 以及细菌或病毒抗原等刺激的反应。NF-κB 在调节对感染的免疫反应中起着关键作用。NF-κB 的错误调节与癌症、炎症和自身免疫性疾病、感染性休克、病毒感染和免疫发育不当有关。NF-κB 还与突触可塑性和记忆过程有关。哺乳动物 NF-κB 家族中有五种蛋白质:NF-κB1、NF-κB2、RelA、RelB、c-Rel。

NF-κB (Nuclear factor kappa-light-chain-enhancer of activated B cells) is a protein complex that controls transcription of DNA. NF-κB is found in almost all animal cell types and is involved in cellular responses to stimuli such as stress, cytokines, free radicals, ultraviolet irradiation, oxidized LDL, and bacterial or viral antigens. NF-κB plays a key role in regulating the immune response to infection. Incorrect regulation of NF-κB has been linked to cancer, inflammatory, and autoimmune diseases, septic shock, viral infection, and improper immune development. NF-κB has also been implicated in processes of synaptic plasticity and memory. There are five proteins in the mammalian NF-κB family: NF-κB1, NF-κB2, RelA, RelB, c-Rel.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-N3188
    Niloticin Inhibitor ≥98.0%
    Niloticin 为四环三萜化合物,是一种破骨细胞生成 (osteoclastogenesis) 抑制剂。Niloticin 具有抗病毒、抗氧化和灭蚊活性。Niloticin 通过阻断 RANKL-RANK 相互作用、抑制 AKTMAPKNF-κB 信号通路抑制破骨细胞形成。
    Niloticin
  • HY-150587
    Anti-inflammatory agent 31 Inhibitor
    Anti-inflammatory agent 31 是一种穿心莲内酯衍生物,是一种抗炎剂 (anti-inflammatory agent)。Anti-inflammatory agent 31 通过上游阻断 PI3K/AktERK1/2 MAPK 激活来抑制 NF-kB 激活。Anti-inflammatory agent 31 能够恢复细胞内 GSH 水平并对肝脏具有保护作用。
    Anti-inflammatory agent 31
  • HY-W041489R
    Chelidonic acid (Standard)

    白屈菜酸 (Standard)

    Inhibitor
    Chelidonic acid (Standard) 是 Chelidonic acid 的分析标准品。本产品用于研究及分析应用。Chelidonic acid 是从 Chelidonium majus L. 中分到的酸类物质,为一种抗菌剂。Chelidonic acid 具有抗炎作用,可能通过抑制 NF-κBcaspase-1 来降低 IL-6 的产生。Chelidonic acid 为 glutamate decarboxylase 抑制剂,Ki 值为 1.2 μM。
    Chelidonic acid (Standard)
  • HY-138956
    MAY0132 Inhibitor
    MAY0132 是一种有效的和选择性的 EPAC2 抑制剂,IC50 为 0.4 μM。MAY0132 能显著抑制 HMPVAdVRSV 的复制,减少病毒感染诱导的细胞因子/趋化因子产生,并抑制 NF-κB 激活。MAY0132 具有抗病毒的活性,可用于呼吸道病毒感染相关研究。
    MAY0132
  • HY-168567
    RIPK2-IN-6 Inhibitor
    RIPK2-IN-6 (Compound 15a) 是 RIPK 的抑制剂,可抑制 RIPK2 的磷酸化,从而抑制 NF-κBMAPK 信号通路。RIPK2-IN-6 在 in Dextran sodium sulfate (HY-116282C) 诱发的小鼠结肠炎模型中表现出抗炎和抗纤维化活性。
    RIPK2-IN-6
  • HY-139716
    IMD-catechol Modulator
    IMD-catechol 是一种新型的NF-κB免疫调节剂二聚体,可提高CT26小鼠结肠癌模型的疗效,同时产生最小的辅助毒性。
    IMD-catechol
  • HY-175293
    SMU-C68 Activator
    SMU-C68 是一种高选择性的小分子 TLR1/2 异源二聚体激动剂 (EC50=0.009 μM)。SMU-C68 可激活 NF-κB 和 MAPK 通路,促进促炎细胞因子 (如 TNF-α、IL-1β) 的释放。SMU-C68 有望用于癌症的研究。
    SMU-C68
  • HY-111214
    K-14585 Inhibitor
    K-14585 是一种肽竞争性 PAR2 拮抗剂。K-14585 可抑制 PAR2 依赖性 IL-8 的产生、NF-κB 磷酸化和 p38 信号传导。K-14585 可降低 SLIGKV (PAR2 激动剂多肽) 诱导的原代人角质形成细胞中的 Ca2+ 动员。
    K-14585
  • HY-N12527
    Hyperelamine A
    Hyperelamine A 是一种多环聚异戊二烯化酰基间苯三酚 (PPAP)。 Hyperelamine A 通过 TLR-4/NF κB 信号传导对 BV-2 细胞中 LPS 激活的 NO 产生具有抑制活性。
    Hyperelamine A
  • HY-124281
    9(R)-PAHSA Inhibitor
    9(R)-PAHSA 是 9-PAHSA 的 R 型对映体。9-PAHSA 是一种口服抗炎脂质,可降低血糖并减少炎症。
    9(R)-PAHSA
  • HY-N0809R
    Sesamolin (Standard)

    芝麻林素 (Standard)

    Inhibitor
    Sesamolin (Standard) 是 Sesamolin 的分析标准品。本产品用于研究及分析应用。Sesamolin 可从Sesamum indicum 中分离得到,具有抗氧化活性。Sesamolin 抑制脂质过氧化,具有神经保护作用。Sesamolinl 通过抑制 JNKp38 MAPKscaspase-3 磷酸化,抑制 MAPK 的级联反应。
    Sesamolin (Standard)
  • HY-173416
    Anti-inflammatory agent 100 Inhibitor
    Anti-inflammatory agent 100 (Compound (+)-4S-23) 是一种抗炎试剂。Anti-inflammatory agent 100 抑制 MAPKNF-κB 信号传导,通过抑制 IκB-α 的磷酸化和阻断磷酸化 p65 的核转位来抑制 NF-κB 通路。Anti-inflammatory agent 100 抑制 NO 的产生 (IC50: 0.5 μM) 以及 TNF-α、IL-6 和 IL-1β 的分泌。
    Anti-inflammatory agent 100
  • HY-N0498R
    Nitidine chloride (Standard)

    氯化两面针碱 (Standard)

    Inhibitor
    Nitidine (chloride) (Standard) 是 Nitidine (chloride) 的分析标准品。本产品用于研究及分析应用。Nitidine chloride 是可从Zanthoxylum nitidum (Roxb) DC 中分离得到一种具有抗疟疾活性的化合物。Nitidine chloride 通过多个靶点通路,发挥抗癌活性,如诱导凋亡,抑制STAT3、DNA拓扑异构酶1和2A、ERKc-Src/FAK 相关信号通路。Nitidine chloride通过MAPKNF-kB途径抑制Lps诱导的炎性细胞因子的产生。
    Nitidine chloride (Standard)
  • HY-N0106R
    (Rac)-Salvianic acid A sodium (Standard)

    (Rac)-丹参素钠 (Standard)

    Inhibitor
    (Rac)-Salvianic acid A (sodium) (Standard) 是 (Rac)-Salvianic acid A (sodium) 的分析标准品。本产品用于研究及分析应用。(Rac)-Salvianic acid A sodium 是 Salvianic acid A (HY-N1913) 的外消旋体。Salvianic acid A 是一种具有口服活性的酚类化合物,可诱导 Nrf2/HO-1 激活并抑制 NF-κB 通路,也可激活线粒体 (Mitochondrial Metabolism) 抗氧化防御系统。Salvianic acid A 具有抗炎、抗氧化、抗凋亡 (Apoptosis) 等作用,具有用于炎症和心脑血管等疾病研究的潜力。
    (Rac)-Salvianic acid A sodium (Standard)
  • HY-N0591R
    Dehydrocostus Lactone (Standard)

    去氢木香烃内酯 (Standard)

    Inhibitor
    Dehydrocostus Lactone (Standard) ((-)-Dehydrocostus lactone (Standard)) 是 Dehydrocostus Lactone (HY-N0591) 的分析标准品。本产品用于研究及分析应用。Dehydrocostus Lactone 是一种可以从 Saussurea lappa 分离得到的天然倍半萜。Dehydrocostus Lactone 具有抗炎、抗菌、抗肿瘤和免疫调节等多种活性。Dehydrocostus Lactone 对 Mycobacterium tuberculosisMIC 为 2 µg/mL。Dehydrocostus Lactone 也可抑制细胞毒性 T 淋巴细胞杀伤活性,诱导肿瘤细胞凋亡 (apoptosis)。
    Dehydrocostus Lactone (Standard)
  • HY-14654B
    Aspirin DL-lysine

    赖氨匹林

    Inhibitor
    Aspirin DL-lysine (ASA DL-lysine) 是一种含有赖氨酸的阿司匹林衍生物。Aspirin DL-lysine 抑制血小板中的环氧合酶 (COX),阻断了血栓素A2 (TXA2) 的合成,从而抑制血小板的聚集和激活。Aspirin DL-lysine 可用于对不稳定型心绞痛患者凝血酶生成的研究。
    Aspirin DL-lysine
  • HY-121239
    Lemnalol Modulator
    Lemnalol 是治疗神经性疼痛的有效试剂。Lemnalol 具有抗炎、镇痛和抗肿瘤活性。Lemnalol 能通过调节神经病变的神经炎症过程减轻痛觉过敏和异常痛觉。Lemnalol 能调节脂多糖 (LPS) 诱导的左心房 (LA) 钙稳态的改变和 NF-κB 通路的阻断,可能有助于心律失常和神经性疼痛的减弱。Lemnalolis 是一种从 lemmnalia cervicorni 中分离得到的甘蓝素型倍半萜类化合物。
    Lemnalol
  • HY-N0705R
    Curculigoside (Standard)

    仙茅苷 (Standard)

    Inhibitor
    Curculigoside (Standard) 是 Curculigoside 的分析标准品。本产品用于研究及分析应用。Curculigoside 是 C. orchioide 中的主要皂苷,具有显着的抗氧化,抗骨质疏松,抗抑郁和神经保护作用。 通过调节 JAK/STAT/NF-κB 信号传导途径,在体内和体外表现出显着的抗关节炎作用。
    Curculigoside (Standard)
  • HY-W705168
    Yangonin-d3

    甲氧醉椒素-d3

    Yangonin-d3 是 Yangonin (HY-N0919) 的氘代物。Yangonin 对人重组大麻素 CB1 受体具有高的亲和力,IC50Ki 分别为 1.79 μM 和 0.72 μM。
    Yangonin-d<sub>3</sub>
  • HY-120269
    CAY10512 Inhibitor
    CAY10512 是一种 NF-κB 抑制剂。CAY10512 能抑制脑脊液和细胞外液中 NF-κB 敏感的促炎性 miRNA (miRNA-9、miRNA-125b、miRNA-146a、miRNA-155) 的上调,可以用于阿尔兹海默症的研究。
    CAY10512
目录号 产品名 / 同用名 应用 反应物种

NF-κB transcription factors are critical regulators of immunity, stress responses, apoptosis and differentiation. In mammals, there are five members of the transcription factor NF-κB family: RELA (p65), RELB and c-REL, and the precursor proteins NF-κB1 (p105) and NF-κB2 (p100), which are processed into p50 and p52, respectively. NF-κB transcription factors bind as dimers to κB sites in promoters and enhancers of a variety of genes and induce or repress transcription. NF-κB activation occurs via two major signaling pathways: the canonical and the non-canonical NF-κB signaling pathways[1]

 

The canonical NF-κB pathway is triggered by signals from a large variety of immune receptors, such as TNFR, TLR, and IL-1R, which activate TAK1. TAK1 then activates IκB kinase (IKK) complex, composed of catalytic (IKKα and IKKβ) and regulatory (NEMO) subunits, via phosphorylation of IKKβ. Upon stimulation, the IKK complex, largely through IKKβ, phosphorylates members of the inhibitor of κB (IκB) family, such as IκBα and the IκB-like molecule p105, which sequester NF-κB members in the cytoplasm. IκBα associates with dimers of p50 and members of the REL family (RELA or c-REL), whereas p105 associates with p50 or REL (RELA or c-REL). Upon phosphorylation by IKK, IκBα and p105 are degradated in the proteasome, resulting in the nuclear translocation of canonical NF-κB family members, which bind to specific DNA elements, in the form of various dimeric complexes, including RELA-p50, c-REL-p50, and p50-p50. Atypical, IKK-independent pathways of NF-κB induction also provide mechanisms to integrate parallel signaling pathways to increase NF-κB activity, such as hypoxia, UV and genotoxic stress.

 

The non-canonical NF-κB pathway is induced by certain TNF superfamily members, such as CD40L, BAFF and lymphotoxin-β (LT-β), which stimulates the recruitment of TRAF2, TRAF3, cIAP1/2 to the receptor complex. Activated cIAP mediates K48 ubiquitylation and proteasomal degradation of TRAF3, resulting in stabilization and accumulation of the NFκB-inducing kinase (NIK). NIK phosphorylates and activates IKKα, which in turn phosphorylates p100, triggering p100 processing, and leading to the generation of p52 and the nuclear translocation of p52 and RELB[2][3].

 

Reference:

[1]. Oeckinghaus A, et al. The NF-kappaB family of transcription factors and its regulation.Cold Spring Harb Perspect Biol. 2009 Oct;1(4):a000034. 
[2]. Taniguchi K, et al. NF-κB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol. 2018 May;18(5):309-324.
[3]. Perkins ND,et al. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol. 2007 Jan;8(1):49-62.

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.